This Week In Medicine cover art

All Episodes

This Week In Medicine — 196 episodes

#
Title
1

NEJM June 2026 Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.

2

May 2026 Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cance

3

NEJM May 2026 Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention

4

NEJM 4 2026 Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

5

NEJM 4 2026 A Multicomponent Intervention to Improve Maternal Infection Outcomes

6

NEJM April 2026 First-Line Zongertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer

7

NEJM 4 23 2026 Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.

8

NEJM 4 23 2206 Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients.

9

NEJM 4 23 2026: Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage

10

JAMA 4 2026 Cost-Effectiveness of ApoB, Non–HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy.

11

JAMA 4 2026 Colorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior Colonoscopy

12

JAMA 4 2026 Real-World Outcomes of Transcatheter Tricuspid Valve Replacement Analysis From the STS/ACC TVT Registry

13

NEJM 4 2026 Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.

14

NEJM 4 2026 eft Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation

15

NEJM 4 2026 Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease

16

NEJM 4 2026 Multifaceted Strategies for Hypertension Control in Low-Income Patients

17

NEJM 4 2026 Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer

18

NEJM 3 26 26 Dengue Suppression by Male Wolbachia-Infected Mosquitoes.

19

NEJM 3 26 26 Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years

20

NEJM 3 26 26 Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer

21

Lancet March 2026 Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study

22

Lancet March 2026 The effectiveness of HPV vaccination against invasive cervical cancer and related precancerous lesions: a multinational target trial emulation study

23

NEJM March 12 2026 Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia

24

NEJM March 12 2026 Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia

25

NEJM March 12 2026 Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

26

JAMA Pediatrics March 2026 Screen Use at Bedtime and Sleep Duration and Quality Among Youths

27

NEJM March 5 2026 Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction

28

NEJM March 5 2026 Finerenone in Type 1 Diabetes and Chronic Kidney Disease

29

JAMA February 2026 Coffee and Tea Intake, Dementia Risk, and Cognitive Function

30

JAMA February 2026 Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation

31

JAMA February 2026 Worldwide Radiation Dose in Coronary Artery Disease Diagnostic Imaging

32

NEJM February 2026 Tecovirimat for the Treatment of Mpox

33

NEJM February 2026 Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges

34

NEJM February 2026 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer

35

Lancet February 2026 Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence B

36

Lancet February 2026 End-to-end integrative segmentation and radiomics prognostic models for risk stratification of high-grade serous ovarian cancer: a retrospective multicohort study

37

Lancet February 2026 Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trial

38

NEJM February 19 2026 An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1

39

NEJM February 19 2026 Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma

40

JAMA February 5 Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke

41

JAMA February 11 Coffee and Tea Intake, Dementia Risk, and Cognitive Function.

42

JAMA February 11 Emergency Department–Initiated Buprenorphine for Opioid Use Disorder

43

NEJM February 2026 Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents

44

NEJM February 2026 A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy

45

NEJM February 2026 Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial

46

Lancet February 2026 Smartwatch-derived versus self-reported outcomes of physiological recovery after COVID-19, influenza, and group A streptococcus: a 2-year prospective cohort study

47

Lancet February 2026, Delirium and adverse clinical outcomes: a matched cohort study in the UK Biobank

48

NEJM February 5,2026 Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer

49

NEJM February 5,2026 Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction.

50

NEJM February 5,2026:A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

51

American Journal of HTN January 2026 Trends in Initial Combination Antihypertensive Therapy in a US Health System

52

JAMA Network Open ID Single-Dose Liposomal Amphotericin Plus Fluconazole and Flucytosine for Cryptococcal Meningitis at a US Public Hospital

53

NEJM January 28, 2026: A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D

54

NEJM January 28,2026 Nivolumab for Resected Stage III or IV Melanoma at 9 Years

55

NEJM January 28,2026 Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation

56

NEJM January 22,2026 Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer

57

NEJM January 22,2026:Nivolumab for Resected Stage III or IV Melanoma at 9 Years

58

NEJM January 22,2026:Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation.

59

NEJM January 2026 Fremanezumab in Children and Adolescents with Episodic Migraine

60

NEJM January 2026 ORIGINAL ARTICLE Share on Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD

61

NEJM January 2026;Medical Management and Revascularization for Asymptomatic Carotid Stenosis

62

Lancet : January 2026 Mortality and long-term exposure to source-specific PM2·5: evidence from a national cohort study in China

63

Lancet : January 2026:SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studies

64

Lancet : January 2026, REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial

65

NEJM January 8, 2026 RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults

66

NEJM January 8, 2026 Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis

67

NEJM January 8, 2026

68

Circulation:January 6, 2026:Circulation:January 6, 2026 Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation

69

Circulation:January 6, 2026 Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial

70

Circulation:January 6, 2026 Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial

71

THE LANCET: December 31, 2025:International trends and social disparities in pain of adults aged 50 years and older in 22 countries across Europe, Asia, and the Americas: a longitudinal population-based study

72

THE LANCET Volume 407, Issue 10523P31-52January 03, 2026 Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

73

N Engl J Med 2026;394:51-61 Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab

74

NEJM: Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC

75

N Engl J Med 2026;394:13-26 Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC

76

Most Popular Articles JAMA 2025 Episode 2:Screening for Osteoporosis to Prevent Fractures US Preventive Services Task Force Recommendation Statement

77

Most Popular Articles JAMA 2025 Episode 1:The DECAF Trial

78

The Lancet December 2025:Neurobehavioural links from infant screen time to anxiety

79

Best of JAMA 2025: Episode 9:Nicotinamide for Skin Cancer Chemoprevention

80

Best of JAMA 2025: Episode 8:Association of Endothelial Dysfunction With Chronic Marijuana Smoking and THC-Edible Use

81

Best of JAMA 2025: Episode 7: Global Estimates of Lives and Life-Years Saved by COVID-19 Vaccination During 2020-2024

82

Best of JAMA 2025: Episode 6:Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration

83

Best of JAMA 2025: Episode 5:Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors A Systematic Review and Individual Participant Data Meta-Analysis

84

Best of JAMA 2025: Episode 4:Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation A Systematic Review and Meta-Analysis

85

Best of JAMA 2025: Episode 3:Genetic Architecture and Risk of Childhood Maltreatment Across 5 Psychiatric Diagnoses

86

Best of JAMA 2025: Episode 2:Projected Lifetime Cancer Risks From Current Computed Tomography Imaging

87

Best of JAMA 2025: Episode 1: Proximity to Golf Courses and Risk of Parkinson Disease

88

Lancet:December 19, 2025: Persistence to antihypertensive drug classes in uncomplicated hypertension: a nationwide Swedish cohort study

89

NATURE:Eleven clinical trials that will shape medicine in 2026

90

The LANCET:Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study Volume 406, Issue 10521P2757-2771December 13, 2025

91

Neurology: High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia Evidence From a 25-Year Prospective Cohort Study

92

JAMA December 2026 Valacyclovir Treatment of Early Symptomatic Alzheimer Disease The VALAD Randomized Clinical Trial

93

Annals of Internal Medicine December 2026 Eligibility and Prognostic Performance of Smoking Duration–Based Versus Pack-Year–Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups

94

NEJM December 2026 Part III

95

NEJM December 2026 Part II

96

NEJM December 11 2026

97

10 27 2025

98

10 21 2025

99

9 29 2025

100

9 22 2025

101

9 15 2025

102

8 25 2025

103

8 18 2025

104

8 11 2025

105

8 4 2025

106

7 28 2025

107

7 21 2025

108

7 14 2025

109

7 7 2025

110

6 30 2025

111

6 9 2025

112

6 2 2025

113

5 26 2025

114

5 19 2025

115

5 1 2025

116

4 21 2025

117

4 14 2025

118

4 7 2025

119

3 31 2025

120

3 24 2025

121

3 17 2025

122

3 10 2025

123

3 3 2025

124

2 24 2025

125

2 17 2025

126

2 10 2025

127

2 3 2025

128

1 27 2025

129

1 20 2025

130

1 13 2025

131

1 6 2025

132

12 30 2024

133

12 23 2024

134

12 16 2024

135

12 9 2024

136

12 2 2024

137

11 25 2024

138

11 18 2024

139

11 7 2024

140

11 4 2024

141

10 28 2024

142

10 21 2024

143

10 14 2024

144

10 7 2024

145

9 30 2024

146

9 23 2024

147

9 16 2024

148

9 9 2009

149

9 2 2023

150

8 26 2024

151

8 19 2024

152

8 12 2024

153

8 5 2024

154

7 29 2024

155

7 22 24

156

6 24 2024

157

6 17 2024

158

6 10 2024

159

6 3 2024

160

5 27 2024

161

5 20 2024

162

5 13 2-24

163

5 6 2024

164

4 29 2024

165

4 22 2024

166

4 15 2024

167

4 8 2024

168

4 1 2024

169

3 25 2024

170

3 18 2024

171

3 11 2024

172

3 5 2024

173

2 26 2024

174

2 19 2024

175

2 12 2024

176

2 5 2024

177

1 29 2024

178

1 22 2024

179

1 15 2024

180

1 8 2024

181

01 01 2024

182

12 25 2023

183

12 18 2023

184

12 11 2023

185

12 4 2023

186

11 27 2023

187

11 20 2023

188

11 13 2023

189

11 6 2023

190

10 30 2023

191

10 23 2023

192

10 16 2023

193

10 9 2023

194

10 2 2023

195

9 25 2023

196

September 21 ,2023